Analgesics
Antiandrogens
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Abstract
All quercetin studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19early.org COVID-19 treatment researchQuercetinQuercetin (more..)
Melatonin Meta
Metformin Meta
Azvudine Meta
Bromhexine Meta Molnupiravir Meta
Budesonide Meta
Colchicine Meta
Conv. Plasma Meta Nigella Sativa Meta
Curcumin Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   

Investigation of potential effects of quercetin on COVID-19 treatment: a systematic review of randomized controlled trials

Beşler et al., Clinical Science of Nutrition, doi:10.62210/ClinSciNutr.2024.86
May 2024  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
Quercetin for COVID-19
22nd treatment shown to reduce risk in July 2021
 
*, now known with p = 0.0031 from 11 studies.
No treatment is 100% effective. Protocols combine complementary and synergistic treatments. * >10% efficacy in meta analysis with ≥3 clinical studies.
4,200+ studies for 70+ treatments. c19early.org
Systematic review of RCTs investigating quercetin for COVID-19. Five studies with a total of 803 participants were included. Authors found that quercetin treatment led to reductions in cases, viral persistence, hospitalization, oxygen requirements, fatigue, and inflammatory markers. Treatment was well-tolerated with no major side effects reported.
Reviews covering quercetin for COVID-19 include1-17.
Beşler et al., 25 May 2024, peer-reviewed, 4 authors. Contact: znbesler@aybu.edu.tr.
This PaperQuercetinAll
Investigation of potential effects of quercetin on COVID-19 treatment: a systematic review of randomized controlled trials
Zehra Nur Beşler, Damla Zeynep Bayraktar, Meryem Cemile Koçak, Gül Kızıltan
Clinical Science of Nutrition, doi:10.62210/clinscinutr.2024.86
Objectives: The COVID-19 pandemic has rapidly become a global health crisis. Currently, there are no proven, reliable, specific treatments for COVID-19. Alongside drug interventions, supportive treatments are implemented during the disease. Quercetin, recognized for its antiviral, anti-inflammatory, anti-aging, and antioxidant properties, is under evaluation in this study for its potential impact on preventing, influencing the course, and mitigating the severity of COVID-19.
Conflict of interest: The authors declare that there is no conflict of interest.
References
Ahmed, Albalawi, Shora, Abdelseed, Al-Kattan, Effects of quadruple therapy: Zinc, quercetin, bromelain and vitamin C on the clinical outcomes of patients infected with COVID-19, Res Int J Endocrinol Diabetes, doi:10.37179/rijed.000005
Ali, Alam, Khatoon, Natural products can be used in therapeutic management of COVID-19: Probable mechanistic insights, Biomed Pharmacother, doi:10.1016/j.biopha.2022.112658
Arslan, Ergun, Topuz, Synergistic effect of quercetin and vitamin C against COVID-19: Is a possible guard for front liners, SSRN Electron J, doi:10.2139/ssrn.3682517
Bastaminejad, Bakhtiyari, Quercetin and its relative therapeutic potential against COVID-19: A retrospective review and prospective overview, Curr Mol Med, doi:10.2174/1566524020999200918150630
Bernini, Velotti, Natural polyphenols as immunomodulators to rescue immune response homeostasis: Quercetin as a research model against severe COVID-19, Molecules, doi:10.3390/molecules26195803
Biancatelli, Berrill, Catravas, Marik, Quercetin and vitamin c: an experimental, synergistic therapy for the prevention and treatment of SARS-CoV-2 related disease (COVID-19), Front Immunol, doi:10.3389/fimmu.2020.01451
Cancio, Ciccocioppo, Rocco, Emerging trends in COVID-19 treatment: learning from inflammatory conditions associated with cellular therapies, Cytotherapy, doi:10.1016/j.jcyt.2020.04.100
Carpinteiro, Edwards, Hoffmann, Pharmacological inhibition of acid sphingomyelinase prevents uptake of SARS-CoV-2 by epithelial cells, Cell Rep Med, doi:10.1016/j.xcrm.2020.100142
Chamorro, Pandolfi, Moreno, Effects of quercetin in a rat model of hemorrhagic traumatic shock and reperfusion, Molecules, doi:10.3390/molecules21121739
Chen, Zheng, Liu, Yan, Xu et al., Plasma CRP level is positively associated with the severity of COVID-19, Ann Clin Microbiol Antimicrob, doi:10.1186/s12941-020-00362-2
Conti, Ronconi, Caraffa, Induction of proinflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVID-19 or SARS-CoV-2): antiinflammatory strategies, J Biol Regul Homeost Agents
Covidence, Cochrane Community
Dabbagh-Bazarbachi, Clergeaud, Quesada, Ortiz, Sullivan et al., Zinc ionophore activity of quercetin and epigallocatechin-gallate: from Hepa 1-6 cells to a liposome model, J Agric Food Chem, doi:10.1021/jf5014633
Derosa, Maffioli, Angelo, Pierro, A role for quercetin in coronavirus disease 2019 (COVID-19), Phytother Res, doi:10.1002/ptr.6887
Gasmi, Mujawdiya, Lysiuk, Quercetin in the prevention and treatment of coronavirus infections: A focus on SARS-CoV-2, Pharmaceuticals, doi:10.3390/ph15091049
Glinsky, Tripartite combination of candidate pandemic mitigation agents: vitamin d, quercetin, and estradiol manifest properties of medicinal agents for targeted mitigation of the COVID-19 pandemic defined by genomicsguided tracing of SARS-CoV-2 targets in human cells, Biomedicines, doi:10.3390/biomedicines8050129
Jakaria, Azam, Jo, Kim, Dash et al., Potential therapeutic targets of quercetin and its derivatives: Its role in the therapy of cognitive impairment, J Clin Med, doi:10.3390/jcm8111789
Jo, Kim, Shin, Kim, Inhibition of SARS-CoV 3CL protease by flavonoids, J Enzyme Inhib Med Chem, doi:10.1080/14756366.2019.1690480
Kamel, Abdelseed, Albalawi, Aslsalameen, Almutairi et al., Evaluation of the effect of zinc, quercetin, bromelain and vitamin C on COVID-19 patients, doi:10.1101/2020.12.22.20245993
Karaağaç, Koyu, Vitamins and minerals in viral infections: a review focusing on COVID-19, İzmir Katip Çelebi University Faculty of Health Science Journal
Karataş, Turhan, Phyto-phospholipid complexes as drug delivery system for herbal extracts/molecules, Artic Turkish J Pharm Sci
Kaul, Paul, Kumar, Büsselberg, Dwivedi et al., Promising antiviral activities of natural flavonoids against SARS-CoV-2 targets: Systematic review, Int J Mol Sci, doi:10.3390/ijms222011069
Kuznetsova, Prange, Glass, De Winther, Transcriptional and epigenetic regulation of macrophages in atherosclerosis, Nat Rev Cardiol, doi:10.1038/s41569-019-0265-3
Lee, Yu, Trimpert, Virus-induced senescence is a driver and therapeutic target in COVID-19, Nature
Li, Yao, Han, Quercetin, inflammation and immunity, Nutrients, doi:10.3390/nu8030167
Magar, Sohng, A Review on structure, modifications and structure-activity relation of quercetin and its derivatives, J Microbiol Biotechnol, doi:10.4014/jmb.1907.07003
Margolin, Luchins, Margolin, Margolin, Lefkowitz, 20-week study of clinical outcomes of over-the-counter COVID-19 prophylaxis and treatment, J Evid Based Integr Med, doi:10.1177/2515690X211026193
Marín-Corral, Rodríguez-Morató, Gomez-Gomez, Metabolic signatures associated with severity in hospitalized COVID-19 patients, Int J Mol Sci, doi:10.3390/ijms22094794
Mendes, Gaspar, Conde, Mano, Duarte, Flavonoid-mediated immunomodulation of human macrophages involves key metabolites and metabolic pathways, Sci Rep, doi:10.1038/s41598-019-51113-z
Moradian, Gouravani, Salehi, Cytokine release syndrome: inhibition of pro-inflammatory cytokines as a solution for reducing COVID-19 mortality, Eur Cytokine Netw, doi:10.1684/ecn.2020.0451
Page, Moher, Bossuyt, PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews, BMJ, doi:10.1136/bmj.n160
Pawar, Russo, Rani, Goswami, Russo et al., A critical evaluation of risk to reward ratio of quercetin supplementation for COVID-19 and associated comorbid conditions, Phytother Res, doi:10.1002/ptr.7461
Pede, Bresciani, Calani, The human microbial metabolism of quercetin in different formulations: An in vitro evaluation, Foods, doi:10.3390/foods9081121
Pierro, Derosa, Maffioli, Possible Therapeutic effects of adjuvant quercetin supplementation against earlystage COVID-19 Infection: A prospective, randomized, controlled, and open-label study, Int J Gen Med, doi:10.2147/IJGM.S318720
Pierro, Iqtadar, Khan, Potential clinical benefits of quercetin in the early stage of COVID-19: Results of a second, pilot, randomized, controlled and open-label clinical trial, Int J Gen Med, doi:10.2147/IJGM.S318949
Riva, Corti, Belcaro, Interaction study between antiplatelet agents, anticoagulants, diabetic therapy and a novel delivery form of quercetin, Minerva Cardioangiol, doi:10.23736/S0026-4725.18.04795-3
Riva, Ronchi, Petrangolini, Bosisio, Allegrini, Improved oral absorption of quercetin from quercetin Phytosome®, a new delivery system based on food grade lecithin, Eur J Drug Metab Pharmacokinet, doi:10.1007/s13318-018-0517-3
Rondanelli, Perna, Gasparri, Promising effects of 3-month period of quercetin Phytosome® supplementation in the prevention of symptomatic COVID-19 disease in healthcare workers: A pilot study, Life, doi:10.3390/life12010066
Sağlık Bakanlığı, Sağlığı, Müdürlüğü, COVID-19 (SARS-CoV-2 Enfeksiyonu) Genel Bilgiler, Epidemiyoloji ve Tanı [COVID-19 (SARS-CoV-2 Infection) General Information, Epidemiology and Diagnosis
Sağlık, Bakanlığı, COVID-19 (SARS-CoV-2 Enfeksiyonu
Schettig, Sears, Klein, COVID-19 patient with multifocal pneumonia and respiratory difficulty resolved quickly: possible antiviral and anti-inflammatory benefits of quercinex (Nebulized Quercetin-NAC) as adjuvant, Adv Infect Dis, doi:10.4236/aid.2020.103006
Shohan, Nashibi, Mahmoudian-Sani, The therapeutic efficacy of quercetin in combination with antiviral drugs in hospitalized COVID-19 patients: A randomized controlled trial, Eur J Pharmacol, doi:10.1016/j.ejphar.2021.174615
Shukor, Camp, Gonzales, Angiotensinconverting enzyme inhibitory effects by plant phenolic compounds: a study of structure activity relationships, J Agric Food Chem, doi:10.1021/jf404641v
Ullah, Munir, Badshah, Important flavonoids and their role as a therapeutic agent, Molecules, doi:10.3390/molecules25225243
Wiersinga, Rhodes, Cheng, Peacock, Prescott, Pathophysiology, transmission, diagnosis, and treatment of coronavirus 2019 (COVID-19): A review, JAMA, doi:10.1001/jama.2020.12839
Xu, Hu, Wang, Cui, Antioxidant activities of quercetin and its complexes for medicinal application, Molecules, doi:10.3390/molecules24061123
Zhao, Di, Xu, The NLRP3 inflammasome and COVID-19: Activation, pathogenesis and therapeutic strategies, Cytokine Growth Factor Rev, doi:10.1016/j.cytogfr.2021.06.002
Zou, Ye, Kamaraj, Zhang, Zhang et al., A review on pharmacological activities and synergistic effect of quercetin with small molecule agents, Phytomedicine, doi:10.1016/j.phymed.2021.153736
Zwicker, Schlechter, Stopa, Targeting protein disulfide isomerase with the flavonoid isoquercetin to improve hypercoagulability in advanced cancer, JCI Insight, doi:10.1172/jci.insight.125851
Önal, Arslan, Ergun, Treatment of COVID-19 patients with quercetin: A prospective, single center, randomized, controlled trial, Turk J Biol, doi:10.3906/biy-2104-16
{ 'indexed': {'date-parts': [[2024, 5, 25]], 'date-time': '2024-05-25T20:40:24Z', 'timestamp': 1716669624721}, 'reference-count': 0, 'publisher': 'Turkish Society of Clinical Enteral and Parenteral Nutrition', 'license': [ { 'start': { 'date-parts': [[2024, 5, 25]], 'date-time': '2024-05-25T00:00:00Z', 'timestamp': 1716595200000}, 'content-version': 'unspecified', 'delay-in-days': 0, 'URL': 'https://creativecommons.org/licenses/by/4.0'}], 'content-domain': {'domain': [], 'crossmark-restriction': False}, 'abstract': '<jats:p>Objectives: The COVID-19 pandemic has rapidly become a global health crisis. ' 'Currently, there are no proven, reliable, specific treatments for COVID-19. Alongside drug ' 'interventions, supportive treatments are implemented during the disease. Quercetin, ' 'recognized for its antiviral, anti-inflammatory, anti-aging, and antioxidant properties, is ' 'under evaluation in this study for its potential impact on preventing, influencing the ' 'course, and mitigating the severity of COVID-19.\r\n' 'Methods: A thorough search was conducted across scientific databases, including PubMed, ' 'Embase, Web of Science, SAGEpub, Copernicus, Cochrane Library, ScienceDirect, Elsevier, ' 'Scopus, Google Scholar, EBSCOhost, Crossref, Ovid-LWW, and DergiPark databases, between 1 ' 'November 2021 and 1 April 2022 to ensure a comprehensive inclusion of relevant studies.\r\n' 'Results: Thirteen randomized controlled clinical trials (five published, eight unpublished) ' 'were identified. Existing literature supports quercetin’s role as a potent free radical ' 'scavenger with robust antioxidant properties. It exhibits anti-inflammatory characteristics ' 'by inhibiting lipid peroxidation and restraining pro-inflammatory enzymes such as ' 'lipoxygenase and phospholipase A2. Scholarly discourse suggests that quercetin ' 'supplementation within the 500-1500 mg range leads to favorable outcomes, including quicker ' 'patient discharge, reduced inflammation, increased respiratory rate, accelerated viral ' 'clearance, and an improved disease prognosis. However, it is noted that intervention ' 'durations vary across studies.\r\n' 'Conclusions: The analysis of the studies suggested that quercetin is a promising therapeutic ' 'agent that can cause a decrease in disease symptoms, frequency of hospitalization, hospital ' 'stay, need for non-invasive oxygen treatment, need for intensive care, and mortality. ' 'Nonetheless, more clinical studies are needed to better understand quercetin’s curative ' 'effects on COVID-19 infection.</jats:p>', 'DOI': '10.62210/clinscinutr.2024.86', 'type': 'journal-article', 'created': {'date-parts': [[2024, 5, 25]], 'date-time': '2024-05-25T20:01:05Z', 'timestamp': 1716667265000}, 'page': '1-11', 'source': 'Crossref', 'is-referenced-by-count': 0, 'title': 'Investigation of potential effects of quercetin on COVID-19 treatment: a systematic review of ' 'randomized controlled trials', 'prefix': '10.62210', 'author': [ { 'ORCID': 'http://orcid.org/0000-0001-5289-696X', 'authenticated-orcid': False, 'given': 'Zehra Nur', 'family': 'Beşler', 'sequence': 'first', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0001-6606-7206', 'authenticated-orcid': False, 'given': 'Damla Zeynep', 'family': 'Bayraktar', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0002-5755-2549', 'authenticated-orcid': False, 'given': 'Meryem Cemile', 'family': 'Koçak', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0001-5012-5838', 'authenticated-orcid': False, 'given': 'Gül', 'family': 'Kızıltan', 'sequence': 'additional', 'affiliation': []}], 'member': '48628', 'published-online': {'date-parts': [[2024, 5, 25]]}, 'container-title': 'Clinical Science of Nutrition', 'original-title': [], 'link': [ { 'URL': 'https://clinscinutr.org/article/download/86/102', 'content-type': 'application/pdf', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://clinscinutr.org/article/download/86/102', 'content-type': 'unspecified', 'content-version': 'vor', 'intended-application': 'similarity-checking'}], 'deposited': { 'date-parts': [[2024, 5, 25]], 'date-time': '2024-05-25T20:01:06Z', 'timestamp': 1716667266000}, 'score': 1, 'resource': {'primary': {'URL': 'https://clinscinutr.org/article/view/86'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2024, 5, 25]]}, 'references-count': 0, 'URL': 'http://dx.doi.org/10.62210/ClinSciNutr.2024.86', 'relation': {}, 'ISSN': ['2667-6230'], 'subject': [], 'container-title-short': 'Clin Sci Nutr', 'published': {'date-parts': [[2024, 5, 25]]}}
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit